Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Medford
A. Medford
Hoffmann-La Roche
In vivo
Medicine
Pharmacology
Chemistry
Leukotriene E4
4
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
S125 Establishing prescribing habits and complication awareness of nitrofurantoin, and the impact of adverse effects following prophylactic prescription
2021
Thorax
N Tuffin
F Mundy-Baird
T Speirs
S. Mulholland
M.G. Morales
H Sakota
Charles Sharp
M. Albur
F. Keeley
A. Medford
H. Burden
E. Jonas
Shaney L Barratt
Huzaifa Adamali
Show All
Source
Cite
Save
Citations (0)
Role of cyclooxygenase products in some of the biological effects of chemically synthesized leukotrienes (B4, C4, D4, and E4).
1983
Advances in prostaglandin, thromboxane, and leukotriene research
Ann F. Welton
Margaret ODonnell
Anderson W
Herman J. Crowley
A. Medford
Beverly A. Simko
Bohdan Yaremko
Show All
Source
Cite
Save
Citations (1)
226 Comparison of the pharmacologic properties of leukotriene E4 (LTE) and platelet activating factor (PAF) in vivo
1983
The Journal of Allergy and Clinical Immunology
Margaret ODonnell
A. Medford
Ann F. Welton
Show All
Source
Cite
Save
Citations (2)
Ro 21-7634, a new antiallergic agent with potent oral activity.
1981
Inflammation Research
Richard A. Salvador
L. B. Czyzewski
Herman W. Baruth
A. Hooper
A. Medford
D.A. Miller
T. Van Trabert
Bohdan Yaremko
Ann F. Welton
Show All
Source
Cite
Save
Citations (11)
1